Recombinant Human CD5L Protein，His

CD5L, also known as CD5 antigen-like protein, is an important protein implicated in various physiological and pathological processes, particularly in the immune system. It is primarily expressed in macrophages, dendritic cells, and other immune cells, playing crucial roles in modulating immune responses and maintaining homeostasis. Recent studies have shown that CD5L functions in diverse areas, such as lipid metabolism, inflammation, and apoptosis. In the context of autoimmune diseases and chronic inflammatory conditions, CD5L has garnered attention for its potential role in regulating the activation and survival of immune cells. Additionally, its involvement in the clearance of apoptotic cells highlights its importance in preventing autoimmunity and promoting tissue repair. As a result, researchers have been keen to explore the therapeutic potential of CD5L, considering its role in various diseases, including atherosclerosis, diabetes, and cancer. The development of recombinant CD5L protein for experimental and clinical applications is vital for understanding its mechanisms of action and potential as a biomarker or therapeutic target. By studying the structural and functional aspects of CD5L, researchers aim to elucidate its roles in immune regulation and disease progression, contributing to the advancement of targeted therapies for immune-mediated disorders. Overall, the exploration of CD5L as a recombinant protein presents opportunities to deepen our understanding of immune biology and develop novel strategies for disease intervention.